WallStreetZenWallStreetZen

NASDAQ: HOWL
Werewolf Therapeutics Inc Stock Ownership - Who owns Werewolf Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Werewolf Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ansbert Gadicke10% Owner2025-10-29134,240$1.55
$208.07kSell
Mpm Bioventures 2014 LP10% Owner2025-10-29134,240$1.55
$208.07kSell
Luke EvninDirector2025-10-2986,154$1.55
$133.54kSell
Luke EvninDirector2025-10-2844,327$1.64
$72.70kSell
Ansbert Gadicke10% Owner2025-10-2869,068$1.64
$113.27kSell
Mpm Bioventures 2014 LP10% Owner2025-10-2869,068$1.64
$113.27kSell
Mpm Bioventures 2014 LP10% Owner2025-10-2772,709$1.72
$125.06kSell
Ansbert Gadicke10% Owner2025-10-2772,709$1.72
$125.06kSell
Luke EvninDirector2025-10-2746,664$1.72
$80.26kSell
Ra Capital Management LPDirector2025-05-14162,539$0.98
$159.29kBuy

1 of 2

HOWL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HOWL insiders and whales buy or sell their stock.

HOWL Shareholders

What type of owners hold Werewolf Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP14.61%6,681,307$10.82MInstitution
Mpm Bioventures 2014 LP14.09%6,442,653$10.44MInsider
Ansbert Gadicke14.09%6,442,653$10.44MInsider
Mpm Asset Management LLC9.42%4,309,860$6.98MInstitution
Luke Evnin9.04%4,132,715$6.69MInsider
James E. Flynn5.58%2,552,787$4.14MInsider
Mpm Bioimpact LLC5.27%2,408,810$3.90MInstitution
Bank Of America Corp4.66%2,129,024$3.45MInstitution
Taiho Ventures LLC4.52%2,068,909$3.35MInsider
Sakae Asanuma4.52%2,068,909$3.35MInsider

1 of 3

HOWL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HOWL40.55%59.45%Net SellingNet Selling
COEP0.33%99.67%
XBIT11.20%46.67%
PMVP57.07%42.93%Net SellingNet Selling
BYSI14.88%12.00%Net SellingNet Selling
View Top Biotech Stocks

Werewolf Therapeutics Stock Ownership FAQ

Who owns Werewolf Therapeutics?

Werewolf Therapeutics (NASDAQ: HOWL) is owned by 48.84% institutional shareholders, 71.62% Werewolf Therapeutics insiders, and 0.00% retail investors. Mpm Bioventures 2014 LP is the largest individual Werewolf Therapeutics shareholder, owning 6.44M shares representing 14.09% of the company. Mpm Bioventures 2014 LP's Werewolf Therapeutics shares are currently valued at $10.05M.

If you're new to stock investing, here's how to buy Werewolf Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.